Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Senti Biosciences (SNTI) Interest & Investment Income (2021 - 2025)

Senti Biosciences (SNTI) has 5 years of Interest & Investment Income data on record, last reported at $166000.0 in Q3 2025.

  • For Q3 2025, Interest & Investment Income rose 10.67% year-over-year to $166000.0; the TTM value through Sep 2025 reached $1.1 million, down 7.26%, while the annual FY2024 figure was $948000.0, 66.9% down from the prior year.
  • Interest & Investment Income reached $166000.0 in Q3 2025 per SNTI's latest filing, down from $270000.0 in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $1.1 million in Q4 2022 and bottomed at $965.0 in Q2 2021.
  • Average Interest & Investment Income over 5 years is $353152.7, with a median of $253000.0 recorded in 2024.
  • Peak YoY movement for Interest & Investment Income: soared 26425.0% in 2023, then crashed 74.27% in 2024.
  • A 5-year view of Interest & Investment Income shows it stood at $8784.0 in 2021, then skyrocketed by 12741.53% to $1.1 million in 2022, then tumbled by 62.23% to $426000.0 in 2023, then crashed by 46.01% to $230000.0 in 2024, then dropped by 27.83% to $166000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Interest & Investment Income were $166000.0 in Q3 2025, $270000.0 in Q2 2025, and $394000.0 in Q1 2025.